| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Deemed dividend relating to inducement of dragasac warrants | - | 0 | 64 | - |
| Income tax expense (benefit) | - | 0 | 0 | - |
| Total net revenues | 5,284 | 5,736 | 11,426 | 9,296 |
| Cost of revenues-Product | 1,666 | 2,550 | 2,506 | - |
| Cost of revenues-Service | 220 | 220 | 209 | - |
| Cost of revenue | - | - | - | 3,883 |
| Cost of revenues-License Royalty And Other | 2,018 | 2,472 | 839 | - |
| Amortization of acquired intangible assets | - | - | 368 | 375 |
| Research and development | 4,598 | 3,352 | 3,728 | 3,915 |
| Selling, general and administrative | 9,306 | 12,634 | 14,262 | 12,650 |
| Amortization of acquired intangible assets | 376 | 372 | - | - |
| Total operating expenses | 18,184 | 21,600 | 21,912 | 20,823 |
| Loss from operations | -12,900 | -15,864 | -10,486 | -11,527 |
| Interest income | 62 | 62 | 76 | 77 |
| Interest expense | 1,477 | 1,943 | 2,437 | 1,752 |
| Change in fair value of warrant liabilities | 4,264 | 1,276 | -242 | -714 |
| Change in fair value of debt | 824 | 1,075 | 12 | 708 |
| Loss on debt extinguishment | -620 | 0 | -5,736 | - |
| Amortization of licensing obligation | 51 | - | - | - |
| Loss on issuance of convertible note with warrants | -2,335 | - | - | - |
| Other expense, net | -769 | -4,428 | -1,401 | -2,902 |
| Total other (expense) income | -10,176 | -8,660 | -9,268 | -4,571 |
| Loss before income taxes | -23,076 | -24,524 | -19,754 | -16,098 |
| Net loss | -23,076 | -24,524 | -19,754 | -16,098 |
| Change in fair value of debt due to change in credit risk, net of tax | - | - | - | -2 |
| Other comprehensive (loss) income | - | - | - | -2 |
| Change in fair value of debt due to change in credit risk, net of tax | 3 | -3 | 5 | - |
| Comprehensive loss | -23,073 | -24,527 | -19,749 | -16,100 |
| Net loss attributable to common shareholders | -23,073 | -24,527 | -19,813 | - |
| Net loss per share - basic | -0.88 | -1.02 | -0.84 | -0.73 |
| Net loss per share - diluted | -0.88 | -1.02 | -0.84 | -0.73 |
| Weighted average shares outstanding - basic | 26,347,818 | 24,020,193 | 23,530,877 | 21,976,339 |
| Weighted average shares outstanding - diluted | 26,347,818 | 24,020,193 | 23,530,877 | 21,976,339 |
Celularity Inc (CELU)
Celularity Inc (CELU)